New York City Mayor Zohran Mamdani, the self-described democratic socialist, has quietly made permanent a controversial program that pays drug users for returning used syringes, embedding the initiative into the city’s massive $126 billion budget.
The Community Syringe Redemption Program, which began as a pilot in early 2025, will now receive $3 million annually. Participants earn 20 cents per returned syringe at eight designated sites across the city. In its first year, the program paid out roughly $292,000 to more than 1,700 individuals.
The funding comes from opioid settlement money, part of broader harm-reduction efforts that also include free distribution of naloxone and fentanyl test strips. Mamdani and his progressive allies argue the initiative helps reduce needlestick injuries, disease transmission, and street litter. However, critics rightly contend that handing out cash to active drug users rewards destructive behavior and places an unnecessary burden on taxpayers already struggling with the city’s ongoing opioid crisis.
This decision comes as New York City continues to grapple with record levels of overdose deaths and public drug use, particularly in areas like Manhattan’s open-air narcotics markets. Opponents argue that instead of enabling addiction through cash incentives, city leaders should focus on expanded treatment, enforcement, and recovery programs that actually help people break free from substance abuse.
Mamdani’s first budget as mayor has drawn sharp criticism from those who see it as another example of radical progressive priorities that prioritize ideology over practical solutions. While the city faces significant fiscal challenges, including past budget shortfalls, resources continue flowing into programs many view as soft on addiction rather than addressing root causes.
Mamdani’s approach to the opioid epidemic has sparked heated debate about whether it is truly helping New Yorkers or fueling the symptoms of a deeper crisis by sustaining the cycle of addiction on city streets.
We bet it is the second.
